Literature DB >> 11081157

Reverse transcription polymerase chain reaction analysis of pituitary hormone, Pit-1 and steroidogenic factor-1 messenger RNA expression in pituitary tumors.

M T McDermott1, B R Haugen, D F Gordon, W M Wood, N S Brown, C A Bauer, M J Garrity, B K Kleinschmidt-DeMasters, K O Lillehei, M H Samuels, T M Bright, E C Ridgway.   

Abstract

Pit-1 is a transcription factor that appears early in embryonic pituitary gland formation and is necessary for the development of somatotropes, lactotropes and thyrotropes. Steroidogenic factor-1 (SF-1) is another early appearing transcription factor that is involved in the development of gonadotropes. In this study we have compared RT-PCR analysis of hormone mRNA with traditional IHC for classification of 27 pituitary tumors and have evaluated the correlation of Pit-1 and SF-1 mRNA with hormone mRNA. RT-PCR detected concordant hormone mRNA in 100% of GH IHC positive, 100% of PRL IHC positive, 33% of TSH IHC positive, and 93% of gonadotropin IHC positive tumors. IHC, however, was concordant in only 71% of GH mRNA positive, 78% of PRL mRNA positive, 17% of TSH beta mRNA positive, and 76% of FSH beta mRNA positive tumors. Pit-1 mRNA was positive in 87% of tumors in which mRNA for GH, PRL or TSH beta was detected and in only 17% of GH, PRL and TSH beta mRNA negative tumors. SF-1 mRNA was positive in 94% of tumors in which mRNA for FSH beta was present and in no FSH beta mRNA negative tumors. We conclude that RT-PCR analysis of hormone mRNA may be more sensitive than traditional hormone IHC for classification of pituitary tumors. Furthermore, tumor Pit-1 mRNA positively correlates with GH, PRL and TSH beta mRNA while tumor SF-1 mRNA correlates well with FSH beta mRNA. Combined analysis of hormone and transcription factor mRNA in pituitary tumor tissue may therefore be a more meaningful approach to pituitary tumor characterization.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 11081157     DOI: 10.1023/a:1009957411973

Source DB:  PubMed          Journal:  Pituitary        ISSN: 1386-341X            Impact factor:   4.107


  21 in total

Review 1.  Genetic basis of endocrine disease: pituitary tumor pathogenesis.

Authors:  I Shimon; S Melmed
Journal:  J Clin Endocrinol Metab       Date:  1997-06       Impact factor: 5.958

2.  The transcription activator steroidogenic factor-1 is preferentially expressed in the human pituitary gonadotroph.

Authors:  S L Asa; A M Bamberger; B Cao; M Wong; K L Parker; S Ezzat
Journal:  J Clin Endocrinol Metab       Date:  1996-06       Impact factor: 5.958

Review 3.  Pit-1 determines cell types during development of the anterior pituitary gland. A model for transcriptional regulation of cell phenotypes in mammalian organogenesis.

Authors:  B Andersen; M G Rosenfeld
Journal:  J Biol Chem       Date:  1994-11-25       Impact factor: 5.157

4.  Pit-1 gene expression in human lactotroph and somatotroph pituitary adenomas is correlated to D2 receptor gene expression.

Authors:  I Pellegrini-Bouiller; I Morange-Ramos; A Barlier; G Gunz; D Figarella-Branger; C Cortet-Rudelli; F Grisoli; P Jaquet; A Enjalbert
Journal:  J Clin Endocrinol Metab       Date:  1996-09       Impact factor: 5.958

Review 5.  Pit-1 gene expression in human pituitary adenomas.

Authors:  I Pellegrini-Bouiller; I Morange-Ramos; A Barlier; G Gunz; A Enjalbert; P Jaquet
Journal:  Horm Res       Date:  1997

6.  Expression and alternative splicing of Pit-1 messenger ribonucleic acid in pituitary adenomas.

Authors:  K Hamada; T Nishi; J Kuratsu; Y Ushio
Journal:  Neurosurgery       Date:  1996-02       Impact factor: 4.654

7.  Pit-1 gene expression in human pituitary adenomas using the reverse transcription polymerase chain reaction method.

Authors:  S Yamada; M Takahashi; M Hara; A Hattori; T Sano; Y Ozawa; Y Shishiba; K Hirata; M Usui
Journal:  Clin Endocrinol (Oxf)       Date:  1996-09       Impact factor: 3.478

8.  Pit-1/GHF-1 expression in pituitary adenomas: further analogy between human adenomas and rat SMtTW tumours.

Authors:  M Delhase; P Vergani; A Malur; B Velkeniers; E Teugels; J Trouillas; E L Hooghe-Peters
Journal:  J Mol Endocrinol       Date:  1993-10       Impact factor: 5.098

9.  Expression of human Pit-1 product in the human pituitary and pituitary adenomas. Immunohistochemical studies using an antibody against synthetic human Pit-1 product.

Authors:  N Sanno; A Teramoto; A Matsuno; R Y Osamura
Journal:  Arch Pathol Lab Med       Date:  1996-01       Impact factor: 5.534

10.  Pituitary specific transcription factor messenger ribonucleic expression in adenomatous and nontumorous human pituitary tissues.

Authors:  R V Lloyd; L Jin; W F Chandler; E Horvath; L Stefaneanu; K Kovacs
Journal:  Lab Invest       Date:  1993-11       Impact factor: 5.662

View more
  1 in total

1.  Clinical Relevance of New World Health Organization Classification System for Pituitary Adenomas: A Validation Study With 2-Year Experience.

Authors:  Seung Woo Hong; Se Hoon Kim; Seung Hoon Lim; Eun Jig Lee; Sun Ho Kim; Cheol Ryong Ku; Eui Hyun Kim
Journal:  Front Oncol       Date:  2021-09-13       Impact factor: 6.244

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.